Cargando…
Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
BACKGROUND: Deregulated purine metabolism is critical for fast-growing tumor cells by providing nucleotide building blocks and cofactors. Importantly, purine antimetabolites belong to the earliest developed anticancer drugs and are still prescribed in clinics today. However, these antimetabolites ca...
Autores principales: | Su, Wen-Jing, Lu, Pei-Zhi, Wu, Yong, Kalpana, Kumari, Yang, Cheng-Kun, Lu, Guo-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841304/ https://www.ncbi.nlm.nih.gov/pubmed/33520699 http://dx.doi.org/10.3389/fonc.2020.583053 |
Ejemplares similares
-
Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020) -
Identification of the mitophagy-related diagnostic biomarkers in hepatocellular carcinoma based on machine learning algorithm and construction of prognostic model
por: Tu, Dao-yuan, et al.
Publicado: (2023) -
Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021) -
A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma
por: Yang, Shengjie, et al.
Publicado: (2022) -
Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2021)